| Keishla Suazo-padilla, | |
|
200 Westpark Dr Ste 325, Peachtree City, GA 30269-3574 | |
| (770) 632-5444 | |
| Not Available |
| Full Name | Keishla Suazo-padilla |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 200 Westpark Dr Ste 325, Peachtree City, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013408178 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | APC006204 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Keishla Suazo-padilla, 200 Westpark Dr Ste 325, Peachtree City, GA 30269-3574 Ph: () - | Keishla Suazo-padilla, 200 Westpark Dr Ste 325, Peachtree City, GA 30269-3574 Ph: (770) 632-5444 |
News Archive
Harvest Technologies Corp. announced today results from the company sponsored 60-patient clinical trial conducted at Sri Ramachandra Medical Center in Chennai, India using the company's BMAC System to treat patients with non-reconstructable Critical Limb Ischemia (CLI). Sri Ramachandra Medical Center is a Harvard Medical international-associated institution based in Chennai, India and one of the largest private healthcare facilities in South Asia.
The global supply of oral cholera vaccines is set to double after WHO approved a third producer, helping to address global shortages and expand access in more countries.
Results of a new study by neuroscientists at the University of Massachusetts Amherst and the University of Toronto suggest that a new treatment approach is needed - and how this may be possible - to address adverse effects of aromatase inhibitors, drugs commonly prescribed to both men and women to prevent recurrence of estrogen-positive breast cancer.
The body plan of an organism, crafted over millennia of evolutionary trial and error, is so exquisitely fine-tuned that even a subtle deviation can be detrimental to individual survival and reproductive success.
ZIOPHARM Oncology, Inc. announced today that Dr. Claire Verschraegen of the University of New Mexico, Albuquerque and first author of the abstract, "A phase II randomized controlled trial of palifosfamide plus doxorubicin vs. doxorubicin in patients with soft tissue sarcoma (PICASSO)," (Abstract #10004) presented in an oral session today updated positive data from PICASSO.
› Verified 7 days ago
Abigail Drew Abel, Counselor Medicare: Not Enrolled in Medicare Practice Location: 211 Prime Pt, Building 2 Suite D, Peachtree City, GA 30269 Phone: 678-788-6025 | |
Tonya Gilmore, Counselor Medicare: Not Enrolled in Medicare Practice Location: 317 Welton Way, Peachtree City, GA 30269 Phone: 678-852-8024 | |
Ann Davidson Sheerin, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 Westpark Dr Ste 130, Peachtree City, GA 30269 Phone: 404-747-7709 | |
Sathiya Priya Palanisamy, Counselor Medicare: Not Enrolled in Medicare Practice Location: 6000 Shakerag Hl Ste 314, Peachtree City, GA 30269 Phone: 404-977-6712 | |
Crystal Johnson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1303 Commerce Dr, Peachtree City, GA 30269 Phone: 770-862-6088 | |
Ashley Ann Bonvillain, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 23 Eastbrook Bnd, Suite 200, Peachtree City, GA 30269 Phone: 770-486-1140 Fax: 678-669-2693 |